{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:58:41Z","timestamp":1792616321506,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lanepe.2024.101002","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:34:15Z","timestamp":1720625655000},"page":"101002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015\u20132027): a nationwide, population-based study"],"prefix":"10.1016","volume":"44","author":[{"given":"Hannah","family":"Crothers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Nabil","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq H.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak J.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2024.101002_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2024.101002_bib2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101002_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2024.02.026","article-title":"Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease","volume":"167","author":"Khrom","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2024.101002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(20)31043-6","article-title":"Projection of liver transplant activity per indication in France and United Kingdom","volume":"73","author":"Connolly","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","article-title":"Liver transplantation in the Nordic countries - an intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013","volume":"50","author":"Fosby","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lanepe.2024.101002_bib6","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/TXD.0000000000000548","article-title":"Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway","volume":"1","author":"Andersen","year":"2015","journal-title":"Transplant Direct"},{"key":"10.1016\/j.lanepe.2024.101002_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2021.11.003","article-title":"Emerging drugs for the treatment of primary sclerosing cholangitis","volume":"62","author":"Abbas","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.lanepe.2024.101002_bib9","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2024.101002_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/ije\/dyx015","article-title":"Data resource profile: hospital Episode statistics admitted patient care (HES APC)","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.101002_bib11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","article-title":"Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process","volume":"161","author":"Ponsioen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2024.101002_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.15701","article-title":"Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018","volume":"51","author":"King","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanepe.2024.101002_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/CLEP.S298770","article-title":"Positive predictive value of diagnostic codes for inflammatory bowel disease in the Danish national patient registry among individuals 50+ years, using patient records as reference standard","volume":"13","author":"Rye","year":"2021","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2024.101002_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ecco-jcc\/jjz185","article-title":"The outcomes of emergency admissions with ulcerative colitis between 2007 and 2017 in England","volume":"14","author":"King","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.lanepe.2024.101002_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67353-3","article-title":"The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK","volume":"10","author":"Keogh","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101002_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.24743","article-title":"Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand","volume":"55","author":"Ngu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lanepe.2024.101002_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lanepe.2024.101002_bib22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.lanepe.2024.101002_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lanepe.2024.101002_bib24","article-title":"Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: a large population-based study","volume":"13","author":"Quaresma","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.lanepe.2024.101002_bib25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1136\/gutjnl-2019-318936","article-title":"IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology","volume":"68","author":"Jones","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib26","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002687","article-title":"Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis","author":"Coward","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanepe.2024.101002_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001241","article-title":"Estimating global trends in total and childhood antibiotic consumption, 2011-2015","volume":"4","author":"Jackson","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.lanepe.2024.101002_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/gutjnl-2022-327845","article-title":"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study","volume":"72","author":"Faye","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(16)30077-2","article-title":"Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China","volume":"1","author":"Kaplan","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib30","article-title":"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study","volume":"374","author":"Narula","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2024.101002_bib31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2013-304636","article-title":"East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort","volume":"63","author":"Burisch","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in olmsted county, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.101002_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101002_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanepe.2024.101002_bib36","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","volume":"68","author":"Choi","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib38","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lanepe.2024.101002_bib39","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.lanepe.2024.101002_bib40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanepe.2024.101002_bib41","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lanepe.2024.101002_bib42","first-page":"A9","article-title":"National audit of diagnosis, management and surveillance in primary sclerosing cholangitis in the United Kingdom","volume":"70","author":"Fatourou","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.lanepe.2024.101002_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10654-023-01028-x","article-title":"Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019","volume":"38","author":"Nasr","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.101002_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.14309\/ajg.0000000000002187","article-title":"Has the incidence of inflammatory bowel disease peaked? Evidence from the population-based NorDIBD cohort 1978-2020","volume":"118","author":"Larsen","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanepe.2024.101002_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102526","article-title":"The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)","volume":"70","author":"Cornillet","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanepe.2024.101002_bib48","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.lanepe.2024.101002_bib49","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1016\/S0168-8278(23)01013-9","article-title":"WED-255 - the socioeconomic status, epidemiology, and outcomes of people living with primary sclerosing cholangitis-inflammatory bowel disease in Ontario, Canada: a two-decade analysis","volume":"78","author":"Leung","year":"2023","journal-title":"J\u00a0Hepatol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:10:55Z","timestamp":1762639855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"alternative-id":["S2666776224001698"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101002","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015\u20132027): a nationwide, population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101002"}}